Identification of a novel target of thiazide diuretics

Journal of Nephrology

Volumn 24, Issue 4, 2011, Pages 391-394

  Eladari, Dominique ^a,b,c   Chambrey, Régine ^a,b  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Hypertension; Pendrin; Sodium transport; Thiazide

Indexed keywords

AMILORIDE; CHLOROTHIAZIDE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT;

ARTICLE; DRUG MECHANISM; ESSENTIAL HYPERTENSION; HUMAN; HYPERTENSION; ION TRANSPORT; METABOLIC SYNDROME X; NATRIURESIS; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRESCRIPTION; SODIUM ABSORPTION; SODIUM EXCRETION; VASODILATATION;

ABSORPTION; ANIMALS; HUMANS; HYPERTENSION; ION TRANSPORT; KIDNEY TUBULES, COLLECTING; MICE; SODIUM; SODIUM CHLORIDE; SODIUM CHLORIDE SYMPORTER INHIBITORS; SODIUM CHLORIDE SYMPORTERS;

EID: 79960308450     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/JN.2011.8403     Document Type: Article

References (12)

1. Guyton AC. Blood pressure control: special role of the kidneys and body fluids. Science. 1991;252:1813-1816.
2. Beyer KH Jr, Baer JE, Russo HF, Noll R. Electrolyte excretion as influenced by chlorothiazide. Science. 1958;127:146-147.
3. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell. 2001;104(4):545-556.
4. Chang SS, Grunder S, Hanukoglu A, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet. 1996;12:248-253.
5. Simon DB, Karet FE, Hamdan JM, DiPietro A, Sanjad SA, Lifton RP. Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet. 1996;13:183-188.
6. Simon DB, Nelson-Williams C, Bia MJ, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;12:24-30.
7. Ji W, Foo JN, O'Roak BJ, et al. Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nat Genet. 2008;40:592-599.
8. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981-2997.
9. Terada Y, Knepper MA. Thiazide-sensitive NaCl absorption in rat cortical collecting duct. Am J Physiol. 1990;259(3 Pt 2):F519-F528.
10. Tomita K, Pisano JJ, Burg MB, Knepper MA. Effects of vasopressin and bradykinin on anion transport by the rat cortical collecting duct: evidence for an electroneutral sodium chloride transport pathway. J Clin Invest. 1986;77:136-141.
11. Tomita K, Pisano JJ, Knepper MA. Control of sodium and potassium transport in the cortical collecting duct of the rat: effects of bradykinin, vasopressin, and deoxycorticosterone. J Clin Invest. 1985;76:132-136.
12. Leviel F, Hubner CA, Houillier P, et al. The Na+-dependent chloride-bicarbonate exchanger SLC4A8 mediates an electroneutral Na+ reabsorption process in the renal cortical collecting ducts of mice. J Clin Invest. May 3;120:1627-35.